National Archives This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.

On Wednesday, May 30, 2018, the President signed into law:

S. 204, the “Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017,” which authorizes certain patients to seek access to certain unapproved investigational drugs directly from a drug sponsor or manufacturer; limits the use of clinical outcomes and liability arising from the provision of such drugs; and provides reporting requirements for the use and outcomes of the new authority.